Beijing's "bio bank" doubled its capacity in two years, and the number of samples reached 1 million

08:13, October 9, 2013 source: in the next two years, the first "biological bank" in China, Beijing clinical data and sample resource bank for major diseases will be doubled, and the number of case samples will reach 1 million Biobank will also realize information docking with 13 major hospitals, update and release all kinds of sample data in real time, and open wider to international scientific research institutions At the second International Conference on the standardization of clinical resource base for major diseases in Beijing hosted by the Municipal Science and Technology Commission, famous experts from many institutions at home and abroad, such as the International Association of biological and environmental sample base, the British biological sample base, Shanghai pharmaceutical clinical research center, BGI, etc., focused on the quality management of biological sample base, the quality control of biological samples, and biological samples of clinical diseases The construction and management of the library has carried out academic exchanges Wang Xiaomin, vice president of Capital Medical University, revealed the specific plan of the second phase construction of "biological bank" Beijing "biological bank" is funded by the Municipal Science and Technology Commission and led by Capital Medical University Now it has built the largest clinical data and sample database of disease in China with more than 50000 clinical data and 300000 samples According to reports, the goal of the second phase construction of "biological bank" is to expand the scale, double the scale of the first phase, and reach 100000 cases and 100 samples At the same time, we need to improve the public information release platform to provide research with disease resource retrieval display and data mining services; further promote the sharing and utilization of disease resources, and give full play to the application value of Beijing "biological bank" in the pharmaceutical industry and clinical research The person in charge of the Municipal Science and Technology Commission said that disease resources are important resources for countries to participate in the international competition in the field of biotechnology in the 21st century The focus of the second phase construction of Beijing "biological bank" is to enhance cooperation and sharing at home and abroad based on the needs of development and application, and to build an important resource platform to lead and drive the development of Beijing's biomedical industry by 2015 At present, the second phase project has started the construction of six disease databases, including cardiovascular database, cerebrovascular database, chronic kidney disease database, diabetes database, hepatitis database and AIDS database According to the construction goal, "bio bank" can update the samples and clinical data information of each database in real time and release them to the public in the future, so as to realize resource retrieval and data mining The application value of Beijing "bio bank" in pharmaceutical industry and clinical research will be brought into full play, and the utilization rate of case resources or samples to provide external services will reach more than 30% (reporter Tong Shuquan)